236 related articles for article (PubMed ID: 23497533)
1. Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience.
Capasso I; Esposito E; Pentimalli F; Montella M; Crispo A; Maurea N; D'Aiuto M; Fucito A; Grimaldi M; Cavalcanti E; Esposito G; Brillante G; Lodato S; Pedicini T; D'Aiuto G; Ciliberto G; Giordano A
J Exp Clin Cancer Res; 2013 Mar; 32(1):14. PubMed ID: 23497533
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience.
Capasso I; Esposito E; Pentimalli F; Crispo A; Montella M; Grimaldi M; De Marco M; Cavalcanti E; D'Aiuto M; Fucito A; Frasci G; Maurea N; Esposito G; Pedicini T; Vecchione A; D'Aiuto G; Giordano A
Cancer Biol Ther; 2010 Dec; 10(12):1240-3. PubMed ID: 20935521
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome components in obese Egyptian children.
Zaki ME; Mohamed SK; Bahgat KA; Kholoussi SM
Ann Saudi Med; 2012; 32(6):603-10. PubMed ID: 23396024
[TBL] [Abstract][Full Text] [Related]
4. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
5. Relation with HOMA-IR and thyroid hormones in obese Turkish women with metabolic syndrome.
Topsakal S; Yerlikaya E; Akin F; Kaptanoglu B; Erürker T
Eat Weight Disord; 2012 Mar; 17(1):e57-61. PubMed ID: 22751273
[TBL] [Abstract][Full Text] [Related]
6. Metabolic alterations in adolescents with obstructive sleep apnea.
Bhushan B; Ayub B; Loghmanee DA; Billings KR
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2368-73. PubMed ID: 26581829
[TBL] [Abstract][Full Text] [Related]
7. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
[TBL] [Abstract][Full Text] [Related]
8. Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.
Kabat GC; Kim MY; Stefanick M; Ho GYF; Lane DS; Odegaard AO; Simon MS; Bea JW; Luo J; Wassertheil-Smoller S; Rohan TE
Int J Cancer; 2018 Aug; 143(3):543-551. PubMed ID: 29488210
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Metabolic Syndrome and Postmenopausal Breast Cancer.
Ekinci O; Eren T; Kurtoglu Yakici M; Gapbarov A; Aydemir MA; Saglam ZA; Alimoglu O
Cir Esp (Engl Ed); 2020 Nov; 98(9):540-546. PubMed ID: 32197778
[TBL] [Abstract][Full Text] [Related]
10. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults.
Seo YG; Song HJ; Song YR
J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):710-725. PubMed ID: 32030917
[TBL] [Abstract][Full Text] [Related]
11. [Metformin hydrochloride ameliorates adiponectin levels and insulin sensitivity in adolescents with metabolic syndrome].
Liang L; Fu JF; Zou CC; Hong F; Wang CL; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):118-21. PubMed ID: 16624028
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein is elevated in obese patients with the metabolic syndrome.
Florez H; Castillo-Florez S; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Lee D; Goldberg R
Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
[TBL] [Abstract][Full Text] [Related]
13. SHBG levels correlate with insulin resistance in postmenopausal women.
Akin F; Bastemir M; Alkiş E; Kaptanoglu B
Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
[TBL] [Abstract][Full Text] [Related]
15. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
16. Is There a Relationship Between Insulin Resistance and Breast Cancer-Related Lymphedema? A Preliminary Study.
Doruk Analan P; Kaya E
Lymphat Res Biol; 2022 Feb; 20(1):76-81. PubMed ID: 33761281
[No Abstract] [Full Text] [Related]
17. Insulin resistance independently influences arterial stiffness in normoglycemic normotensive postmenopausal women.
Park JS; Nam JS; Cho MH; Yoo JS; Ahn CW; Jee SH; Lee HS; Cha BS; Kim KR; Lee HC
Menopause; 2010 Jul; 17(4):779-84. PubMed ID: 20215975
[TBL] [Abstract][Full Text] [Related]
18. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
19. The atypical presentation of the metabolic syndrome components in black African women: the relationship with insulin resistance and the influence of regional adipose tissue distribution.
Jennings CL; Lambert EV; Collins M; Levitt NS; Goedecke JH
Metabolism; 2009 Feb; 58(2):149-57. PubMed ID: 19154946
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk in metabolically healthy but overweight postmenopausal women.
Gunter MJ; Xie X; Xue X; Kabat GC; Rohan TE; Wassertheil-Smoller S; Ho GY; Wylie-Rosett J; Greco T; Yu H; Beasley J; Strickler HD
Cancer Res; 2015 Jan; 75(2):270-4. PubMed ID: 25593034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
